Tirofiban efficacy and safety for percutaneous coronary intervention in patients with acute coronary syndrome: protocol for a systematic review and meta-analysis. [PDF]
Gigliotti DA+4 more
europepmc +1 more source
Relationship Between Timing of PCSK9 Inhibitor Monoclonal Antibody Initiation and Clinical Outcomes in Patients with Prior Cardiovascular Events. [PDF]
Sidelnikov E+6 more
europepmc +1 more source
The impact of clinical phenotypes of coronary artery disease on outcomes in patients with atrial fibrillation: A post-hoc analysis of GLORIA-AF registry. [PDF]
Huang B+7 more
europepmc +1 more source
Screening for Dyslipidemia Among Patients Admitted With Acute Coronary Syndrome at the Jakaya Kikwete Cardiac Institute, Tanzania: A Retrospective Cohort Study. [PDF]
Kiroga N, Khan Z.
europepmc +1 more source
Prevalence of Angina Pectoris: An Analysis of the National Health Interview Survey (NHIS) Database. [PDF]
Agho AV+7 more
europepmc +1 more source
Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES. [PDF]
Geba GP+11 more
europepmc +1 more source
Errors in the Results, Table 2, Figures 2 and 3, and Supplement 1.
europepmc +1 more source
Related searches:
The recent availability of novel antiplatelet and antithrombin agents has revolutionized the therapeutic options for intermediate- and high-risk unstable angina (UA). Current guidelines recommend aspirin, unfractionated heparin (UFH), and antianginal therapy.
Timothy D. Henry, M. Bilal Murad
openaire +3 more sources